Blog
RSS FeedPosted by Michael Wonder on 05 Feb 2019
Biosimilar uptake drivers
5 February 2019 - Information about Government initiatives to encourage the use of biosimilars is now available on the PBS website. ...
Posted by Michael Wonder on 21 Jan 2019
Europe closer to biosimilar rule change, despite fierce resistance from pharma
18 January 2019 - EFPIA says it weakens IP commitment - supporters say it will boost exports. ...
Posted by Michael Wonder on 21 Jan 2019
Canadian payer reports a successful switch to biosimilars
21 January 2019 - In 2018, Green Shield Canada launched its pilot Biosimilar Transition Program, through 3 plan sponsors, under which ...
Posted by Michael Wonder on 14 Jan 2019
Samsung faces resistance from big pharma in the U.S.
11 January 2019 - Incumbent biologic drug makers use rebates and exclusive contracts to fend off competition from new entrants. ...
Posted by Michael Wonder on 07 Dec 2018
Underuse of innovative medicines in Germany: A justification for government intervention?
6 December 2018 - The German market for innovative medicines is characterised by simultaneous underuse and overuse. ...
Posted by Michael Wonder on 19 Nov 2018
Novartis joins call asking FDA to stop biosimilar trash-talkers
17 November 2018 - Novartis has joined Pfizer in asking FDA to stop campaigns from branded drugmakers that the pharmas ...
Posted by Michael Wonder on 15 Nov 2018
German health minister calls for faster adoption of biosimilar drugs
14 November 2018 - Germany’s health minister Jens Spahn has called for faster adoption of cheaper copies of biotech drugs ...
Posted by Michael Wonder on 05 Nov 2018
Report on the collection of under co-payment data 2017-18
5 November 2018 - The report on the collection of under co-payment data 2017-18 is now available. ...
Posted by Michael Wonder on 02 Nov 2018
Drug Utilisation Sub-Committee outcome statement - September 2018
2 November 2018 - The outcome statement from the September 2018 Drug Utilisation Sub Committee meeting is now available. ...
Posted by Michael Wonder on 23 Oct 2018
Biosimilar adalimumab: a landmark for NHS medicines optimisation
23 October 2018 - The NHS’s bid to improve patient outcomes and save money by switching costly biological drugs for ...
Posted by Michael Wonder on 13 Sep 2018
Improving understanding of biosimilars in the EU
13 September 2018 - New information material made available in several European languages. ...
Posted by Michael Wonder on 06 Sep 2018
UK lags behind most of Europe in access to biologics for patients with rheumatoid arthritis
4 September 2018 - Global leader in biosimilars, Celltrion Healthcare announces support for the easing of initiation boundaries for biologics that ...
Posted by Michael Wonder on 03 Sep 2018
Biosimilar awareness initiative – literature review
3 September 2018 - The biosimilar literature review update for the period March 2018 to May 2018 is now available. ...
Posted by Michael Wonder on 22 Aug 2018
PBAC Drug Utilisation Sub-Committee utilisation analysis - public release documents
22 August 2018 - The utilisation analysis public release documents from the February 2018 DUSC meeting are now available. ...
Posted by Michael Wonder on 02 Aug 2018
NHS saved £324 million by switching to biosimilars and generics
2 August 2018 - The UK’s national healthcare provider saved £324 million by switching its patients to “better value” biosimilar ...